Notched Noise Therapy for Suppression of Tinnitus
Key facts
- Who runs it
- VA Office of Research and Development
- Where
- Durham, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 108 people enrolled
- Started
- 1 Mar 2023
- Ended
- 31 May 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hearing Aid and Notched Noise Therapy
- Hearing Aid and Broadband Noise
- Hearing Aid
- Record updated
- 14 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Candidates must meet the following inclusion criteria to qualify:
- Veteran
- no active middle-ear disease
- at least one air conduction hearing threshold of 40 dB HL or worse in each ear between .25-8 kHz as measured at the first study visit
- unilateral or bilateral constant tinnitus
- index score on the Tinnitus Functional Index (TFI) of at least 25 (out of a maximum score of 100)
- a score of 24 or higher on the Mini Mental State Exam (MMSE)
- a tinnitus pitch match between 2-10 kHz (and achieve desired level of precision as described below in 3.3 Study Procedures, Tinnitus Psychoacoustic Assessment)
- demonstrates understanding of the requirements of the study
- motivated and capable of participating (including ability to communicate in English)
Who cannot take part
- suspicion of secondary (somatic) tinnitus, Meniere's disease, or tinnitus potentially related to temporo-mandibular disorder or whiplash (any of which can be ruled out with an examination by an appropriate physician)
- any mental, emotional, or health conditions that would preclude full study participation
- The following exclusion criteria will be used:
- two or more hearing thresholds exceeding 70 dB HL
- significant conductive hearing loss-defined as an air-bone gap of 15 dB at more than two frequencies in one ear, or an air-bone gap greater than 15 dB at any one frequency
Where in United States
- Durham VA Medical Center, Durham, NCDurham, United States
About the trial
What the trial wants to find out
Tinnitus ("ringing in the ears") has long been a problem for Veterans. The problem continues to escalate due to high levels of noise in the military, and because tinnitus often is associated with traumatic brain injury and post-traumatic stress disorder. In spite of limited research support, sound-based (acoustic) therapies are most often used for tinnitus intervention, and increasing numbers of commercial devices are becoming available that offer various acoustic-stimulus protocols. The proposed study will provide evidence from a randomized controlled trial comparing effects of acoustic-stimulus methods that are purported to suppress tinnitus and/or reduce its functional effects. The study will focus on methods with the strongest scientific rationale, i.e., noise that is notched around the predominant tinnitus-frequency region. Special ear-level devices will deliver these acoustic-therapy protocols that are purported to modify tinnitus-related neural activity. The study will follow a study recently completed by the applicant that provides preliminary evidence supporting this method.
The 3 groups in the trial
- Amplification + Notched Noise TherapyTreatment being tested
Following the baseline assessment, participants will be randomly assigned to one of the study groups. This treatment group will include a Notched Noise Therapy, a 1-10 kHz noise "notched" within a 1-octave range centered around the psychoacoustic tinnitus pitch match measured. Randomized participants will wear their hearing aids with this loaded software for 8 weeks. They will be seen at a baseline, 4 week, and 8 week visits for outcome measures and any adjustments in hearing aid comfort.
Treatment: Hearing Aid and Notched Noise Therapy
- Amplification + Broadband NoiseExisting treatment, for comparison
Following the baseline assessment, participants will be randomly assigned to one of the study groups. A popular and commonly used sound therapy treatment, this treatment group will listen to a broadband noise, or "white noise," that is housed on the manufacturer's hearing aid tinnitus program. They will be seen at a baseline, 4 week, and 8 week visits for outcome measures and any adjustments in hearing aid comfort.
Treatment: Hearing Aid and Broadband Noise
- Amplification OnlyPlacebo, for comparison
Following the baseline assessment, participants will be randomly assigned to one of the study groups. Hearing aids are ear-level, self-contained, FDA-approved hearing device. Hearing aids help individuals with hearing loss and provide safe amplification/gain to frequencies that have loss.
Treatment: Hearing Aid
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Notched Noise Therapy for Suppression of Tinnitus: A Randomized Controlled Trial
- Record updated
- 14 September 2026